STAT
AUGUST 8, 2024
Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.
Pharma Times
AUGUST 8, 2024
The study predicted the development of conditions including Alzheimer’s and heart disease
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 8, 2024
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday. Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.
PharmaVoice
AUGUST 8, 2024
The top drugs at each of the world’s most valuable pharma companies tell the story of just how much the industry has changed over the course of a few years.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
AUGUST 8, 2024
The company that claimed its AI model could identify sexually transmitted infections from a single penis picture was shut down by the Federal Trade Commission in July. STAT wrote about the app, Calmara, and the immediate critical response it drew from patient advocates, doctors, and privacy experts in April. The founders did not adequately explain how they would protect minors from accessing the app and sensitive user information.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
AUGUST 8, 2024
The liver is one of the few organs that need not be transplanted whole. It can be split into parts, with one part going to one person needing a new liver and the other part going to a second one. Removing barriers to this procedure, known as split liver transplantation, could reduce the number of deaths caused by liver failure. Here’s a real-life illustration (the names have been changed to protect privacy): Jacob was born with a rare disease that damaged his liver and needed a transplant
PharmaVoice
AUGUST 8, 2024
Through a new deal, Roche has exclusive rights to Sangamo molecules designed to repress the gene that makes “tau,” a protein many scientists view as a main driver of Alzheimer’s.
STAT
AUGUST 8, 2024
Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia, said Thursday that they will merge into one company. The new company will continue using the Recursion name and be led by Recursion co-founder and CEO Chris Gibson. Exscientia’s interim CEO, David Hallett, will serve as the company’s science chief.
The Pharmacist
AUGUST 8, 2024
The shortage of blood stocks, particularly group O red cells, remains acute, and the NHS’s amber alert remains in place. Pharmacies have a role to play in encouraging more blood donors, says Dr Avinash Hari Narayanan, clinical lead at the London Medical Laboratory The NHS continues to appeal for people with O-type blood to donate, […] The post Pharmacies can play a vital role in encouraging blood donations appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
AUGUST 8, 2024
This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? The cherry on top. This kind of market exclusivity is only possible because of patents.
pharmaphorum
AUGUST 8, 2024
Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million
STAT
AUGUST 8, 2024
Hunger killed an estimated 4 million people in Ukraine between 1932 and 1933 — the result of Holodomor, a famine inflicted by the Stalin-led Soviet regime. New research shows how the harm experienced during famines can extend even to people who haven’t yet been born. The study , published Thursday in Science, strengthens the link between fetal exposure to famine and increased risk for type 2 diabetes later on in life.
pharmaphorum
AUGUST 8, 2024
Roche is said to be considering a sale of cancer data specialist Flatiron Health, just a few years after it bought the company for $1.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
AUGUST 8, 2024
Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 billion to $46.6 billion from the previously guided range of $42.4 to $43.6 billion. It also raised its guidance for adjusted earnings per share to a range of $16.10 to $16.60 from the previously guided $13.50 to $14.00.
BioPharma Dive
AUGUST 8, 2024
Sales of the in-demand obesity drug crested $1 billion in the second quarter as improved Lilly production helped the company fulfill wholesaler backorders.
STAT
AUGUST 8, 2024
Digital Therapeutics developer Big Health this week received Food and Drug Administration clearance for SleepioRx, a prescription treatment for insomnia. Big Health already sells a wellness version of the app, called Sleepio, to employers and health plans that make the product available to their members. The app delivers a specialized type of cognitive behavioral therapy for insomnia and the company boasts that it is backed by dozens of studies.
BioPharma Dive
AUGUST 8, 2024
After months of supply strains, Lilly has begun to catch up with demand. Consumers may still need to wait for their prescriptions to be filled, however.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
STAT
AUGUST 8, 2024
As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its Alabama hospitals: Florida’s Orlando Health. Orlando Health draws more than $6 billion in annual revenue and has a profit margin that surpasses most of its peers. A hospital system executive system leader said crossing state lines to buy five Birmingham-area hospitals is part of its focus on serving the Southeastern U.S., even though most of its 17 existing hospitals are still in Fl
The Pharmacist
AUGUST 8, 2024
A further baby died from whooping cough in England in June, bringing the total to 10 since the start of the latest outbreak in November last year. New data published today by the UK Health Security Agency (UKHSA) also revealed laboratory confirmed cases during the outbreak has now surpassed 10,000. In response, UKHSA reiterated advice […] The post Another baby dies from whooping cough as cases surpass 10,000 appeared first on The Pharmacist.
STAT
AUGUST 8, 2024
Once again, Novo Nordisk has been admonished by a U.K. trade group for violating voluntary marketing codes and discrediting the entire pharmaceutical industry — and the move comes just one year after the company was suspended from the organization for the way it promoted an obesity drug. In the latest episode, the company was cited for “misleading” and “unbalanced” comments made by its chief executive officer, Lars Fruergaard Jørgensen, to The Sunday Times
pharmaphorum
AUGUST 8, 2024
Novartis gets FDA accelerated approval for Fabhalta in IgA nephropathy as it charts a course to blockbuster sales for the drug
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
AUGUST 8, 2024
Why did Novo Nordisk pull its paperwork to expand the use of Wegovy for a common type of heart failure? How will we know if the the government gets a good deal in the first round of drug pricing negotiations? And has Allison thought about anything other than venture capital for the last couple of months? We discuss all that and more on this week’s episode of “The Readout LOUD.
pharmaphorum
AUGUST 8, 2024
Discover why pharmaceutical companies are trusted less than a waiter, but more than a pilot, and explore the role of Patient Advocacy Groups (PAGs) in shaping trust in the pharmaceutical industry.
STAT
AUGUST 8, 2024
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably more when the injectable treatment was obtained at pharmacies rather than injected in physician offices due to different methods for determining payment, a new analysis found. The drug in question is Stelara, which is made by Johnson & Johnson and approved to combat psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
pharmaphorum
AUGUST 8, 2024
Discover how your work habits and processes may be hindering your digital success in the pharmaceutical industry. Find out how you can invest in digital strategies for better outcomes.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 8, 2024
Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
Pharmaceutical Technology
AUGUST 8, 2024
Novartis has secured US Food and Drug Administration (FDA) accelerated approval for Fabhalta (iptacopan) to treat igAN.
STAT
AUGUST 8, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I fractured my elbow over the weekend. I’ll spare you all the details except to say scampering across slippery rocks is not a great idea. Perhaps my biggest mistake was believing that I’m nimble enough to scamper over anything.
Expert insights. Personalized for you.
363 
Let's personalize your content